Kara Lassen
Direktor/Vorstandsmitglied bei MOONLAKE IMMUNOTHERAPEUTICS
Ursprung des Netzwerks ersten Grades von Kara Lassen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 15 | |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland.
12
| Subsidiary | Real Estate Development | 12 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kara Lassen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chairman Corporate Officer/Principal Human Resources Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Chairman | |
WD-40 COMPANY | Industrial Specialties | Director/Board Member | |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Equipment/Instruments | Trading-Equity Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Human Resources Officer Chief Executive Officer | |
Roche Holdings, Inc.
Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Chairman | |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Executive Officer | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
FORMA THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
UCB | Pharmaceuticals: Major | Director/Board Member | |
Vanderbilt University | College/University | Undergraduate Degree | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Arizona State University | College/University | Undergraduate Degree Masters Business Admin | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
Yale University | College/University | Graduate Degree Corporate Officer/Principal | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree | |
Rensselaer Polytechnic Institute | College/University | Doctorate Degree | |
West Virginia University | College/University | Graduate Degree | |
University of Mumbai | College/University | Undergraduate Degree | |
University of Groningen | College/University | Doctorate Degree Undergraduate Degree | |
The Genentech Foundation | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Roche Deutschland Holding GmbH
Roche Deutschland Holding GmbH Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Deutschland Holding GmbH is a German company that manufactures and distributes pharmaceutical products. The company is based in Grenzach-Wyhlen, Germany. The CEOs are Claudia Fleischer, Hagen Pfundner, Ulrich Winkel. The company was founded in 1997 by Fritz Hoffmann-La Roche. Roche Deutschland Holding was acquired by NEXUS AG on November 30, 2018. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Roche Pharma AG
Roche Pharma AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma AG is a world leader in innovative cancer drugs and has brought many highly effective drugs onto the market. The company is based in Grenzach-Wyhlen, Germany. The German company also focuses on viral infections, metabolic, central nervous system disorders, and inflammatory diseases. Roche Diagnostics, a subsidiary of Roche Pharma, develops diagnostic tests, instruments, and digital solutions to transform healthcare globally. Roche has been committed to improving lives since its founding in 1896 and creates innovative medicines and diagnostic tests that help millions of patients worldwide. | Medical Distributors | Director/Board Member Chairman | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
BiVACOR, Inc.
BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Medical Specialties | Director/Board Member | |
ALLAKOS INC. | Pharmaceuticals: Major | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Juvenile Diabetes Research Foundation
Juvenile Diabetes Research Foundation Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation operates an organization focused on treating and preventing diabetes. The private company is based in Shrewsbury. | Miscellaneous Commercial Services | Director/Board Member | |
EQUILLIUM, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Ventus Therapeutics, Inc.
Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member | |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Chairman | |
CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Blossom Biosciences Ltd.
Blossom Biosciences Ltd. BiotechnologyHealth Technology Blossom Biosciences Ltd. provides molecular and cell biology research services. The company is based in Hong Kong, Hong Kong. Andrew J. Phillips has been the CEO of the Chinese company since 2021. | Biotechnology | Chief Executive Officer | |
CARGO THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Aleksia Therapeutics, Inc. | Chief Executive Officer | ||
Moonlake Immunotherapeutics Ltd. | Director/Board Member Chief Tech/Sci/R&D Officer | ||
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Godfrey Huggins School of Medicine | College/University | Undergraduate Degree | |
Klarman Cell Observatory | Director/Board Member |
Statistik
International
Vereinigte Staaten | 36 |
Deutschland | 4 |
Vereinigtes Königreich | 4 |
Niederlande | 3 |
Schweiz | 2 |
Sektoral
Health Technology | 24 |
Consumer Services | 11 |
Finance | 5 |
Commercial Services | 4 |
Distribution Services | 3 |
Operativ
Director/Board Member | 115 |
Corporate Officer/Principal | 61 |
Independent Dir/Board Member | 32 |
Chairman | 26 |
Undergraduate Degree | 22 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Catherine Moukheibir | 29 |
Gottlieb A. Keller | 26 |
Severin Schwan | 23 |
Andrew Phillips | 23 |
Alan Hippe | 20 |
Simon Sturge | 20 |
Dolca Thomas | 14 |
Frank Lee | 13 |
Cynthia Burks | 12 |
Patrícia Isabel Sousa Caldinha | 11 |
Ramnik Xavier | 11 |
Kristian Reich | 10 |
Flavia Borellini | 9 |
Spike N. Loy | 9 |
Matthias Bodenstedt | 7 |
- Börse
- Insiders
- Kara Lassen
- Unternehmensverbindungen